RECRUITING
I'm interested ...!!
Tolerability, Acceptance, and Utility of Intermittent CGM Use in Youth With Prediabetes
We are evaluating whether intermittent use of continuous glucose monitors (CGMs) in addition to standard nutritional counseling and physical activity counseling is associated with improved metabolic health for youth with pre-diabetes (PD).
Conditions:
🦠 PreDiabetes 🦠 Obesity 🦠 Insulin Resistance
🗓️ Study Start (Actual) 5 June 2023
🗓️ Primary Completion (Estimated) 30 January 2025
✅ Study Completion (Estimated) 30 January 2025
👥 Enrollment (Estimated) 33
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Birmingham, Alabama, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Age 14 or older
    • * English-speaking
    • * stable metformin dose for 1 month prior to enrollment or no metformin use
    • * baseline A1c of 5.7-6.4%
    • * tanner stage 3 or above
    • * BMI \> = 85% for age

    Exclusion Criteria:

    • * BMI \< 85% for age
    • * chronic steroid use
    • * diagnosis of type 1 diabetes, type 2 diabetes, other forms of diabetes
    • * current or history of malignancy
Ages Eligible for Study: 14 Years to N/A (CHILD, ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 15 August 2022
  • First Submitted that Met QC Criteria 15 August 2022
  • First Posted 17 August 2022

Study Record Updates

  • Last Update Submitted that Met QC Criteria 12 June 2024
  • Last Update Posted 13 June 2024
  • Last Verified June 2024
I'm interested ...!!